170403 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving growth factors Epidermal growth factor [EGF] (urogastrone)
METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#2COMPOSITIONS AND METHODS FOR ANALYSIS, DETECTION, AND TREATMENT OF MULTIPLE SCLEROSIS
#3METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#4EGFL6 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE
#5Method of Predicting a Patient's Benefit From Therapy with an Immune Checkpoint Inhibitor
#6COMPOUNDS AND METHODS TARGETING EPIREGULIN
#7COLON CANCER DIAGNOSIS OR DETECTION COMPOSITION FOR PREDICTING RESPONSE TO DRUG, AND COMPOSITION FOR PREVENTING OR TREATING COLON CANCER
#8HETEROCYCLIC INHIBITORS OF EGFR AND/OR HER2, FOR USE IN THE TREATMENT OF CANCER
#9MATERIALS AND METHODS FOR PERFORMING HISTOCHEMICAL ASSAYS FOR HUMAN PRO-EPIREGULIN AND AMPHIREGULIN
#10KINDLIN-1 AS A MARKER OF SENSITIVITY TO EGFR/RAS PATHWAY INHIBITORS
#11Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#12COMPOUNDS AND METHODS TARGETING EPIREGULIN
#13Biomarkers of fast progression of chronic kidney disease
#14COLORECTAL CANCER SCREENING EXAMINATION AND EARLY DETECTION METHOD
#15IN VITRO NEPHROTOXICITY SCREENING ASSAY
#16Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#17METHODS OF TREATING CANCER BASED ON IDENTIFYING MUTATIONS IN THE EXTRACELLULAR DOMAIN III OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE
#18EGFL6 specific monoclonal antibodies and methods of their use
#19IN VITRO SCREENING METHOD AND KIT FOR EARLY DIAGNOSIS OF ORAL CAVITY TUMOURS
#20Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulin
#21Certain chemical entities, compositions, and methods
#22Method for predicting response of esophagus cancer to anti-ERBB3 antibody therapy, and kit
#23Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#24Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#25Use of biomarkers in determining susceptibility to disease treatment
#26USE OF MEGF11 AS DIAGNOSTIC AND PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR TRIPLE NEGATIVE BREAST CANCER
#27METHOD FOR EVALUATING EFFECT OF CYTOKINE ON METABOLIC ACTIVITY OF CYTOCHROME P450, AND DRUG SCREENING METHOD
#28BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#29Ca2+ regulated binding agents
#30Biomarker Panel For Diagnosing Cancer
#31METHODS FOR PREVENTION AND TREATMENT OF CARDIOMETABOLIC SYNDROME AND COMPOSITIONS USED THEREIN
#32In vitro nephrotoxicity screening assay
#33Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2
#34EGFL6 specific monoclonal antibodies and methods of their use
#35Anti amphiregulin antibodies, compositions comprising same and uses thereof
#36HER2 peptide regents and methods
#37Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#38Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulin
#39Biomarkers Related to Treatment of Cancer with HER3 and EGFR Inhibitors
#40Methods of developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics
#41Biomarker panel for diagnosing cancer
#42MONOCLONAL AND OLIGOCLONAL ANTI-EGFR ANTIBODIES FOR USE IN THE TREATMENT OF TUMORS EXPRESSING PREDOMINANTLY HIGH AFFINITY EGFR LIGANDS OR TUMORS EXPRESSING PREDOMINANTLY LOW AFFINITY EGFR LIGANDS
#43METHODS OF MEASURING ERBB SIGNALING PATHWAY ACTIVITY TO DIAGNOSE AND TREAT CANCER PATIENTS
#44BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#45ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF
#46ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS
#47Method of treating cancer based on identifying mutations in the extracellular domain III of epidermal growth factor receptor gene
#48Epidermal Growth Factor Receptor (EGFR) Protein SRM Assay
#49Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#50Molecular analysis of tumor samples
#51ANTIBODIES AND METHODS OF USING SAME FOR TREATING ErbB/ErbB LIGANDS ASSOCIATED DISEASES
#52Adult stem cells derived from human skin dermis
#53Diagnosis of urothelial cancer
#54Method of treatment of chlamydial infections with selected EGFR inhibitors
#55Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
#56Diagnosis of cancer by detecting auto-antibodies against epidermal growth factor (EGF)
#57Biomarker panel for assessment of mucosal healing
#58Diagnosis of cancer by detecting auto-antibodies against EGF-receptor
#59ANTI AMPHIREGULIN ANTIBODIES, COMPOSITIONS COMPRISING SAME AND USES THEREOF
#60Herbal Combinations for Treating Eczema
#61Collagens as markers for breast cancer treatment
#62Biomarkers and methods for progression prediction for chronic kidney disease
#63METHODS FOR PREVENTION AND TREATMENT OF CARDIOMETABOLIC SYNDROME AND COMPOSITIONS USED THEREIN
#64Biomarkers for Tuberculosis
#65BIOMARKERS FOR LOWER URINARY TRACT SYMPTOMS (LUTS)
#66Diagnostic markers for multiple sclerosis
#67METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#68Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#69Methods of developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics
#70Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS
#71MONOCLONAL AND OLIGOCLONAL ANTI-EGFR ANTIBODIES FOR USE IN THE TREATMENT OF TUMORS EXPRESSING PREDOMINANTLY HIGH AFFINITY EGFR LIGANDS OR TUMORS EXPRESSING PREDOMINANTLY LOW AFFINITY EGFR LIGANDS
#72Peptide with gold binding and EGFR receptor affinity and same attached to gold nanostructure
#73METHODS OF PREDICTING RESPONSIVENESS OF A CANCER TO AN AGENT AND METHODS OF DETERMINING A PROGNOSIS FOR A CANCER PATIENT
#74Method for treating a disease originated from receptor activation by EREG and TGFα
#75Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition
#76Biomarkers and methods for measuring and monitoring inflammatory disease activity
#77Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
#78HER3 protein SRM/MRM assay
#79Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
#80Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
#81Method for evaluating effect of cytokine on metabolic activity of cytochrome P450, and drug screening method
#82Diagnosis and risk stratification of bladder cancer
#83Method and compositions for treating cancer and related methods
#84BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY
#85Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#86METHODS FOR DIAGNOSING OSTEOARTHRITIS
#87BIOMARKERS FOR LOWER URINARY TRACT SYMPTOMS (LUTS)
#88NON-INVASIVE METHODS FOR ASSESSING OOCYTE QUALITY FOR IN VITRO FERTILIZATION
#89Monoclonal antibodies to EGFR, and uses therefor
#90KRT19 stabilizing HER2 and use thereof
#91SRM/MRM assay for the receptor tyrosine-protein kinase erbB-4 protein (HER4)
#92Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
#93Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and EGFR inhibitor
#94Detection of targets using magnetic resonance
#95Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#96Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
#97Her3 protein SRM/MRM assay
#98Method for predicting breast cancer patient response to combination therapy
#99Method for assay on the effect of vascularization inhibitor
#100Mutant epidermal growth factor polypeptides with improved biological activity and methods of their making and use
#101Antibodies and methods of using same for treating ErbB/ErbB ligands associated diseases
#102Epidermal Growth Factor Receptor (EGFR) Protein SRM Assay
#103Epidermal growth factor receptor mutations
#104Method and compositions for treating cancer and related methods
#105Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies
#106METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2
#107BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS
#108GENERATION, CHARACTERIZATION AND USES THEREOF OF ANTI-HER3 ANTIBODIES
#109Method for predicting breast cancer patient response to endocrine therapy
#110Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
#111Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component
#112Assay for anti-EGFRvIII antibodies
#113BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY
#114METHOD FOR THE DIAGNOSIS OF AGE-ASSOCIATED VASCULAR DISORDERS
#115BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS
#116Biomarkers and methods for measuring and monitoring inflammatory disease activity
#117SERUM PROTEOMIC FOR FINDING DIAGNOSTIC MARKERS AND FOR MONITORING THERAPEUTICAL INTERVENTION IN TREATMENT OF HEPATOCELLULAR CARCINOMA
#118COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CANCER
#119Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 Antibodies
#120Detecting Cell Surface Markers
#121PRESENT INVENTION RELATES TO METHODS FOR PREDICTION OF THE THERAPEUTIC SUCCESS OF BREAST CANCER THERAPY
#122Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing
#123METHOD FOR DETECTING TRUNCATED MOLECULES
#124NOVEL ASSAY FOR INHIBITORS OF EGFR
#125METHODS FOR PREDICTING A PATIENT'S RESPONSE TO EGFR INHIBITORS
#126GENE EXPRESSION MARKERS OF TUMOR RESISTANCE TO HER2 INHIBITOR TREATMENT
#127NOVEL MARKER FOR SENSITIVITY AGAINST SULFONAMIDE COMPOUND
#128Method for assessing risk of heart failure
#129SYNERGISTIC TREATMENT OF CELLS THAT EXPRESS EPHA2 AND ERBB2
#130Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr Levels
#131Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
#132METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#133Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
#134METHODS AND USES RELATED TO RHBDL4
#135METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT
#136Method for assay on the effect of vascularization inhibitor
#137Modulation of epidermal growth factor heterodimer activity
#138Diagnosis and treatment of cancer using anti-EREG antibody
#139METHODS FOR PREDICTING A PATIENT'S RESPONSE TO EGFR INHIBITORS
#140Diagnostic tests and personalized treatment regimes for cancer stem cells
#141Identification of a family of secreted proteins in vascular endothelium
#142Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
#143Diagnostic panel of cancer antibodies and methods for use
#144Surface Receptor Complexes as Biomarkers
#145Method, compositions and classification for tumor diagnostics and treatment
#146Receptor Tyrosine Kinase Signaling Pathway Analysis For Diagnosis And Therapy
#147SELECTING PATIENTS FOR THERAPY WITH A HER INHIBITOR
#148Soluble ErbB3 methods of detection and antibodies
#149Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#150AMPHIREGULIN ANTIBODIES AND THEIR USE TO TREAT CANCER AND PSORIASIS
#151Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#152Mutations in ErbB2 associated with cancerous phenotypes
#153ERBB HETERODIMERS AS BIOMARKERS
#154Method for the diagnosis of chronic stress and related disorders
#155Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#156Growth Factor Treatment for Asthma
#157RAPID METHOD FOR DETECTING MUTATED GENES
#158Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
#159Identification of a family of secreted proteins in vascular endothelium
#160Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
#161Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
#162SALIVARY PROTEIN AND RNA FOR BREAST CANCER DETECTION
#163Epidermal growth factor receptor mutations
#164Method for predicting the response to a treatment
#165Protein scaffolds and uses thereof
#166Heregulin variants
#167Method, compositions and classification for tumor diagnostics and treatment
#168Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#169Selecting patients for therapy with a her inhibitor
#170Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
#171Methods for detecting receptor complexes comprising PI3K
#172Methods for Detecting Receptor Complexes Comprising PDGFR
#173Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
#174ErbB surface receptor complexes as biomarkers